[Late results of radiotherapy of soft tissue sarcoma].
OBJECTIVE
To evaluate the effect of radiation therapy in the treatment of soft-tissue sarcomas.


METHODS
Between March 1970 and January 1990, 58 patients with soft-tissue sarcoma were referred for radiation therapy. The most frequent histologic diagnoses included fibrosarcoma (n = 15), neurofibrosarcoma (n = 5) and rhabdomyosarcoma (n = 5). Central tumor sites in the trunk (n = 31) were much more frequent than in the head and neck region (n = 14) or the extremities (n = 13). Thirty-nine of 58 primary tumors were bigger than 5 centimeters. Forty-five patients were irradiated after surgery, 5 patients prior to surgery; in 8 cases only radiation therapy was used. Radiation therapy was performed with Co-60 photons and an average total dose of 58 Gy, fractionated in single doses of 2 Gy. The treatment results were obtained by actual follow-up examinations.


RESULTS
Twenty-three of 58 patients survived at least 5 years (39.9%). Of 15 patients with R0 resection 11 were alive after 5 years (73.3%). Local tumor control was achieved in 34 of 58 patients (58.6%). Low 5-year-survival rates were associated with dedifferentiation of the primary tumor (three survivors in 10 patients with G3 tumor), tumor diameters over 5 cm (13 survivors of 39), R2 resection (3 survivors of 16) and tumor sites in the body trunk (11 survivors of 31).


CONCLUSIONS
(1) The best results of radiation therapy were achieved after R0 resection of the primary tumor. (2) Tumors in the trunk are prognostically worse because of bigger tumor diameters due to later diagnosis.
Klinik für Strahlentherapie (Radioonkologie) im Klinikum, Christian-Albrechts-Universität zu Kiel.
J
J
Schultze
B
B
Schwick
R
R
Galalae
B
B
Kimmig
D005260:Female; D005354:Fibrosarcoma / Q000532:radiotherapy; D006801:Humans; D007890:Leiomyosarcoma / Q000532:radiotherapy; D008279:Magnetic Resonance Imaging; D008297:Male; D018319:Neurofibrosarcoma / Q000532:radiotherapy; D012208:Rhabdomyosarcoma / Q000532:radiotherapy; D012509:Sarcoma / Q000145:classification / Q000532:radiotherapy*; D012983:Soft Tissue Neoplasms / Q000532:radiotherapy*; D016896:Treatment Outcome